Spray-drying is a preferred process for manufacturing amorphous solid dispersions, which provide oral bioavailability enhancement for low-solubility small molecules. High permeability, low-solubility ...

Bausch Health’s RED-C phase 3 clinical programme of amorphous-rifaximin SSD in adults with liver cirrhosis for primary prevention of HE fails to meet primary endpoint: Laval, Ca ...

Raman imaging and scanning electron microscopy (SEM) was used to investigate acetaminophen solid dispersions prepared by hot melt extrusion (HME). This experiment confirmed that a high screw speed ...

Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success. Low aqueous solubility and poor bioavailability are ...

Recent work by a team of researchers at Queen’s University Belfast and University College London has reported on a newly developed strategy for the manufacture of a high drug loaded amorphous solid ...

"Codis is built on a foundation of scale, quality, and global reach," said Nicolas Fortin, Codis CEO. "With a total of 40,000 m 2 of manufacturing space, three GMP facilities and with 7 of regulatory ...

The Formulation Science and Technology (FST) Interest Group of the Royal Society of Chemistry is pleased to announce the ‘Innovations in the formulation of Amorphous Solid Dispersions 2023’. This will ...

Shares of Bausch Health (NYSE:BHC) dropped about 8% in early trading on Friday after the company disclosed unsuccessful ...

New global CDMO combines commercial spray drying and particle engineering technologies under one brand. Codis formed through integration of Particle Dynamics and the former EUROAPI site in Haverhill, ...